Journal Title：International Cancer Conference Journal

this Online-only Journal Publishes Original Case Reports On All Types Of Cancer. In Particular, We Welcome Not Only Case Reports Of Educational Value In The Diagnosis And Treatment Of Cancers, But Also Reports On Molecularly Analyzed Cancer Cases, Including Gene Mutations, Gene Fusions, Gene Expression, And Changes In Copy Number, Regardless Of Their Known Clinical Significance. Assessing The Molecular Analysis Of A Tumor Usually Requires A “cancer Conference” In Which Experts From Various Fields Discuss It. Even If The Authors And Their Respective “cancer Conference” Were Unable To Determine The Clinical Significance Of Molecular Changes At The Time Of Submission And Publication, Their Data May Provide Evidence That Will Help The Scientific Community Develop Precision Medicine Solutions In The Future. We Welcome Case Reports With Reviews Of The Literature On Similar Cases, As They Are More Useful And Valuable To Readers Than Are Reports Of Rare Cases. International Cancer Conference Journal Is The Official Publication Of The Japan Society Of Clinical Oncology (jsco).

- Presents An Online-only Collection Of Original Case Reports On All Types Of Cancer

- In Particular, Welcomes Molecularly Analyzed Cancer Cases

- The Official Publication Of The Japan Society Of Clinical Oncology (jsco)

本在線期刊發(fā)表所有類型癌癥的原創(chuàng)病例報告。特別是，我們不僅歡迎在癌癥診斷和治療方面具有教育價值的病例報告，也歡迎對癌癥病例進行分子分析的報告，包括基因突變、基因融合、基因表達和拷貝數(shù)變化，無論其已知的臨床意義如何。評估腫瘤的分子分析通常需要召開“癌癥會議”，各領(lǐng)域的專家會對此進行討論。即使作者及其各自的“癌癥會議”在提交和發(fā)表時無法確定分子變化的臨床意義，他們的數(shù)據(jù)也可能提供證據(jù)，幫助科學(xué)界在未來開發(fā)精準醫(yī)療解決方案。我們歡迎病例報告和對類似病例的文獻評論，因為它們對讀者來說比罕見病例報告更有用、更有價值?！秶H癌癥會議期刊》是日本臨床腫瘤學(xué)會 (jsco) 的官方出版物。

- 提供所有類型癌癥的原始病例報告的在線集合

- 特別歡迎分子分析的癌癥病例

- 日本臨床腫瘤學(xué)會 (jsco) 的官方出版物

International Cancer Conference Journal收稿方向涵蓋ONCOLOGY全領(lǐng)域，平均審稿速度 ，影響因子指數(shù)0.5，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。